نتائج البحث

Proteomic Changes Induced by the Immunosuppressant Everolimus in Human Podocytes.

• Authors : Bruschi, Maurizio^1,2 (AUTHOR) ; Granata, Simona³ (AUTHOR) ; Candiano, Giovanni¹ (AUTHOR)

Subjects: *EVEROLIMUS; *CELL cycle regulation; *PROTEOMICS

• Source: International Journal of Molecular Sciences. Jul2024, Vol. 25 Issue 13, p7336. 17p.

تفاصيل العنوان

Everolimus Treatment for Chronic Lung Allograft Dysfunction in Lung Transplantation.

• Authors : Iturbe-Fernández, David¹ (AUTHOR) ; de Pablo Gafas, Alicia² (AUTHOR) ; Mora Cuesta, Víctor Manuel¹ (AUTHOR)

• Source: Life (2075-1729). May2024, Vol. 14 Issue 5, p603. 9p.

تفاصيل العنوان

Comparison of the effect of Everolimus, Prednisolone, and a combination of both on experimentally induced peritoneal adhesions in rats.

• Authors : Kazemi, Kourosh¹ (AUTHOR); Jamshidi, Kamran² (AUTHOR); Naseri, Reyhaneh³ (AUTHOR)

• Source: Scientific Reports. 5/14/2024, Vol. 14 Issue 1, p1-7. 7p.

تفاصيل العنوان

Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma.

• Authors : Nghiemphu, Phioanh; Vitte, Jeremie; Dombi, Eva

Subjects: Clinical trial; Everolimus; Mammalian target of rapamycin (mTOR) inhibitors

• Source: Journal of Neuro-Oncology. 167(2)

تفاصيل العنوان

مقایسه اثر بخشی و ایمنی پروتکل استفاده Denovo از Everolimus با دوز پایین سیکلوسپورین در برابر پروتکل با دوز استاندارد سیکلوسپورین و Cellcept بر پیشگیری از ایجاد عفونت CMV و BK virus و میزان بقای شش ماه و یکساله پیوند در گیرندگان پیوند کلیه.

• Authors : نوشین دلیلی¹ ; فاطمه پوررضاقلی¹; مریم السادات موس¹

Subjects: *ADRENOCORTICAL hormones; *KIDNEY transplantation; *PATIENT safetyIRAN

• Source: Journal of Ilam University of Medical Sciences. 2024, Vol. 32 Issue 1, p13-25. 13p.

تفاصيل العنوان

A Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With The Physician's Choice of Endocrine Therapy Plus Everolimus in Participants With Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer (evERA Breast Cancer)

• Source: A Phase III, Randomized, Open-Label, Multicenter Study Evaluating the Efficacy and Safety of Giredestrant Plus Everolimus Compared With The Physician's Choice of

تفاصيل العنوان

Everolimus Acts in Synergy with Vinorelbine to Suppress the Growth of Hepatocellular Carcinoma.

• Authors : Huynh, Hung¹ (AUTHOR) ; Ng, Wai Har¹ (AUTHOR); Soo, Khee Chee² (AUTHOR)

Subjects: *EVEROLIMUS; *HEPATOCELLULAR carcinoma; *VINORELBINE

• Source: International Journal of Molecular Sciences. Jan2024, Vol. 25 Issue 1, p17. 20p.

تفاصيل العنوان

Comparing Retreatment of 177Lu-DOTATATE PRRT Versus Everolimus in Patients With Metastatic Unresectable Midgut Neuroendocrine Tumors, NET RETREAT Trial

• Source: NET RETREAT: A Phase II Study of 177 Lutetium-DOTATATE Retreatment vs. Everolimus in Metastatic/Unresectable Midgut NET

تفاصيل العنوان

A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

• Source: Phase IV, Prospective Single Arm Study of Safety and Efficacy of Votubia (Everolimus) in Taiwanese Adults With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma

تفاصيل العنوان

Everolimus Aging Study (EVERLAST)

• Authors : National Institute on Aging (NIA)

• Source: Clinical Evaluation of mTORC1 Inhibition for Geroprotection

تفاصيل العنوان